R
75.31
-0.49 (-0.65%)
| Penutupan Terdahulu | 75.80 |
| Buka | 75.50 |
| Jumlah Dagangan | 1,492,966 |
| Purata Dagangan (3B) | 2,264,512 |
| Modal Pasaran | 14,558,914,560 |
| Harga / Jualan (P/S) | 9.04 |
| Harga / Buku (P/B) | 9.41 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| EPS Cair (TTM) | -4.01 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.46% |
| Nisbah Semasa (MRQ) | 13.46 |
| Aliran Tunai Operasi (OCF TTM) | -591.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -349.13 M |
| Pulangan Atas Aset (ROA TTM) | -23.09% |
| Pulangan Atas Ekuiti (ROE TTM) | -36.68% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Revolution Medicines, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.2
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.20 |
|
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 2.02% |
| % Dimiliki oleh Institusi | 105.87% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 99.00 (Truist Securities, 31.46%) | Beli |
| Median | 76.50 (1.58%) | |
| Rendah | 70.00 (Wells Fargo, -7.05%) | Beli |
| Purata | 79.33 (5.34%) | |
| Jumlah | 12 Beli | |
| Harga Purata @ Panggilan | 55.50 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wolfe Research | 18 Nov 2025 | 75.00 (-0.41%) | Beli | 70.58 |
| HC Wainwright & Co. | 06 Nov 2025 | 73.00 (-3.07%) | Beli | 61.38 |
| JP Morgan | 06 Nov 2025 | 82.00 (8.88%) | Beli | 61.38 |
| Needham | 06 Nov 2025 | 72.00 (-4.40%) | Beli | 61.38 |
| 11 Sep 2025 | 66.00 (-12.36%) | Beli | 46.24 | |
| Wedbush | 06 Nov 2025 | 80.00 (6.23%) | Beli | 61.38 |
| 17 Oct 2025 | 77.00 (2.24%) | Beli | 54.10 | |
| RBC Capital | 03 Nov 2025 | 77.00 (2.24%) | Beli | 59.33 |
| Mizuho | 21 Oct 2025 | 90.00 (19.51%) | Beli | 53.49 |
| Raymond James | 17 Oct 2025 | 76.00 (0.92%) | Beli | 54.10 |
| 12 Sep 2025 | 72.00 (-4.40%) | Beli | 46.55 | |
| Stifel | 16 Oct 2025 | 85.00 (12.87%) | Beli | 49.68 |
| Goldman Sachs | 12 Sep 2025 | 73.00 (-3.07%) | Beli | 46.55 |
| Wells Fargo | 11 Sep 2025 | 70.00 (-7.05%) | Beli | 46.24 |
| Truist Securities | 05 Sep 2025 | 99.00 (31.46%) | Beli | 40.50 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ANDERS JACK | - | 76.32 | -5,418 | -413,502 |
| GOLDSMITH MARK A | - | 76.32 | -66,000 | -5,037,120 |
| Jumlah Keseluruhan Kuantiti Bersih | -71,418 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -5,450,622 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 76.32 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| GOLDSMITH MARK A | Pegawai | 25 Nov 2025 | Jual automatik (-) | 60,000 | 76.32 | 4,579,200 |
| GOLDSMITH MARK A | Pegawai | 25 Nov 2025 | Jual (-) | 6,000 | 76.32 | 457,920 |
| GOLDSMITH MARK A | Pegawai | 25 Nov 2025 | Pelaksanaan pilihan | 60,000 | - | - |
| ANDERS JACK | Pegawai | 25 Nov 2025 | Jual automatik (-) | 5,418 | 76.32 | 413,502 |
| ANDERS JACK | Pegawai | 25 Nov 2025 | Pelaksanaan pilihan | 5,418 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |